Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial
David I. Quinn, Catherine M. Tangen, Maha Hussain, Primo N. Lara, Amir Goldkorn, Carol M. Moinpour, Mark G. Garzotto, Philip C. Mack, Michael A. Carducci, J. Paul Monk, Przemyslaw W. Twardowski, Peter J. Van Veldhuizen, Neeraj Agarwal, Celestia S. Higano, Nicholas J. Vogelzang, Ian M. Thompson
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial'. Together they form a unique fingerprint.